People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Laxmi Therapeutic Devices, Inc. | — | Biotech / Pharma | Series A | $58.2M | $75.2M | 2016 |
Bill Van Antwerp at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bill Van Antwerp on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Rule | 1 | 3 |
| Matthew Berger | 1 | 2 |
| John Gerngross | 1 | 1 |
| Luke Theogarajan | 1 | 1 |
| Greg Snelson | 1 | 1 |
| Rachael Scherer | 1 | 1 |
| Radhika Krishnan | 1 | 1 |
| Radhika Krishman | 1 | 1 |
| Sumita Pennathur | 1 | 1 |
| Bill Van Antwery | 1 | 1 |
| Richard Low | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.